Table 3.

Immunohistological findings and Epstein–Barr virus infection in 42 cases of liver-involving B-cell lymphoma

Histological type	CD5	CD10	Bcl2	Bcl6	MUM1	CD25	EBERs
Primary hepatic B-cell lymphoma
DLBCL: 12	3 (25%)	4 (33.3%)	6 (50%)	5 (41.7%)	5 (41.7%)	5 (41.7%)	2 (16.7%)
MALT: 8	0/7 (0)	0 (0)	8 (100%)	0/6 (0)	0 (0)	0 (0)	0 (0)
Liver-involving systemic B-cell lymphoma
IVLBCL: 12	3/10 (30%)	0/11 (0)	8/10 (80%)	1/10 (10%)	10 (83.3%)	2 (16.7%)	0 (0)
DLBCL: 10	1/9 (11.1%)	1 (10%)	8/9 (88.9%)	2/9 (22.2%)	8 (80%)	3/9 (33.3%)	0 (0)

/: positive/examined cases. EBERs Epstein–Barr encoded RNAs, DLBCL diffuse large B-cell lymphoma, MALT mucosa-associated lymphoid tissue, IVLBCL intravascular large B-cell lymphoma